Dafni_C
☆    

Cyprus,
2024-01-17 11:00
(241 d 10:12 ago)

Posting: # 23829
Views: 1,893
 

 Subject effect justification [General Sta­tis­tics]

Post reply
We have performed a bioequivalence study which passed the acceptance criteria. However there is a subject (sequence) effect for for ln-transformed pharmacokinetic parameters Cmax, AUC0-t and AUC0-∞. How this can be justified that doesn't affect the study results?:confused::confused:
 
Relaxation
★    

Germany,
2024-01-17 13:30
(241 d 07:42 ago)

@ Dafni_C
Posting: # 23831
Views: 1,526
 

 Subject effect justification

Post reply
Dear Dafni_C.

Just for clarification of the background.
You conducted an ANOVA (or mixed effects model) with the effects "treatment", "sequence" and "period" as well as the effect "subject(sequence)"?
And in your "ANOVA"-table the p-value of "subject(sequence)" was found to be statistically significant?

There are more qualified persons here, but ...
this indicates that the subjects in the trial were different people, so that normally would be expected to be "significant", right?

If you mean the "sequence" effect or something else, you may find the information available in the "Articles" (see header at the very top) helpful.

Best regards!
 
UA Flag
Activity
 Admin contact
23,224 posts in 4,878 threads, 1,652 registered users;
36 visitors (0 registered, 36 guests [including 4 identified bots]).
Forum time: 22:12 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5